Jazowiecka-Rakus J - Search Results

1

In vivo gene transfer using cetylated polyethylenimine.

Sochanik A, Cichoń T, Makselon M, Strózyk M, Smolarczyk R, Jazowiecka-Rakus J, Szala S. Sochanik A, et al. Acta Biochim Pol. 2004;51(3):693-702. Acta Biochim Pol. 2004. PMID: 15448731

2

Antitumour activity of Salmonella typhimurium VNP20047 in B16(F10) murine melanoma model.

Jazowiecka-Rakus J, Szala S. Jazowiecka-Rakus J, et al. Acta Biochim Pol. 2004;51(3):851-6. Acta Biochim Pol. 2004. PMID: 15448746

3

Combination of vasostatin gene therapy with cyclophosphamide inhibits growth of B16(F10) melanoma tumours.

Jazowiecka-Rakus J, Jarosz M, Szala S. Jazowiecka-Rakus J, et al. Acta Biochim Pol. 2006;53(1):199-202. Epub 2005 Dec 21. Acta Biochim Pol. 2006. PMID: 16388313

4

Combination of vasostatin and cyclophosphamide in the therapy of murine melanoma tumors.

Jazowiecka-Rakus J, Jarosz M, Kozłowska D, Sochanik A, Szala S. Jazowiecka-Rakus J, et al. Acta Biochim Pol. 2007;54(1):125-33. Epub 2007 Mar 20. Acta Biochim Pol. 2007. PMID: 17369879

5

Vasostatin increases oxygenation of B16-F10 melanoma tumors and raises therapeutic efficacy of cyclophosphamide.

Cichoń T, Jarosz M, Smolarczyk R, Ogórek B, Matuszczak S, Wagner M, Mitrus I, Sochanik A, Jazowiecka-Rakus J, Szala S. Cichoń T, et al. Acta Biochim Pol. 2012;59(3):377-81. Epub 2012 Sep 3. Acta Biochim Pol. 2012. PMID: 22946026

6

Therapeutic antitumor potential of endoglin-based DNA vaccine combined with immunomodulatory agents.

Jarosz M, Jazowiecka-Rakus J, Cichoń T, Głowala-Kosińska M, Smolarczyk R, Smagur A, Malina S, Sochanik A, Szala S. Jarosz M, et al. Gene Ther. 2013 Mar;20(3):262-73. doi: 10.1038/gt.2012.28. Epub 2012 Apr 12. Gene Ther. 2013. PMID: 22495576

7

Gene expression profile of B 16(F10) murine melanoma cells exposed to hypoxic conditions in vitro.

Olbryt M, Jarzab M, Jazowiecka-Rakus J, Simek K, Szala S, Sochanik A. Olbryt M, et al. Gene Expr. 2006;13(3):191-203. doi: 10.3727/000000006783991818. Gene Expr. 2006. PMID: 17193925 Free PMC article.

8

Mesenchymal stem cells as carriers for systemic delivery of oncolytic viruses.

Hadryś A, Sochanik A, McFadden G, Jazowiecka-Rakus J. Hadryś A, et al. Among authors: jazowiecka rakus j. Eur J Pharmacol. 2020 May 5;874:172991. doi: 10.1016/j.ejphar.2020.172991. Epub 2020 Feb 7. Eur J Pharmacol. 2020. PMID: 32044323 Free article. Review.

9

Myxoma Virus-Loaded Mesenchymal Stem Cells in Experimental Oncolytic Therapy of Murine Pulmonary Melanoma.

Jazowiecka-Rakus J, Sochanik A, Rusin A, Hadryś A, Fidyk W, Villa N, Rahman MM, Chmielik E, Franco LS, McFadden G. Jazowiecka-Rakus J, et al. Mol Ther Oncolytics. 2020 Jul 6;18:335-350. doi: 10.1016/j.omto.2020.07.003. eCollection 2020 Sep 25. Mol Ther Oncolytics. 2020. PMID: 32775618 Free PMC article.

10

COVID-19 Autopsies: A Case Series from Poland.

Chmielik E, Jazowiecka-Rakus J, Dyduch G, Nasierowska-Guttmejer A, Michalowski L, Sochanik A, Ulatowska-Bialas M. Chmielik E, et al. Among authors: jazowiecka rakus j. Pathobiology. 2021;88(1):78-87. doi: 10.1159/000512768. Epub 2020 Nov 30. Pathobiology. 2021. PMID: 33254171 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters